Applicants choose Carnegie Mellon University over other, equally competitive schools for a number of reasons. The University's world-class research and researchers in the fields of systems, software engineering, human computer interaction, language technology, and computational biology is paramount in their decision-making. Graduates report that their studies in areas such as large scale systems and industry best practices are well-regarded and highly sought after by corporate recruiters.
The course work and projects included in the M.S. in Biotechnology Innovation and Computation program are all designed around current challenges and research areas related to the biotechnology, pharmaceutical and health care industries. Students learn how to be forward-thinking by evaluating emerging trends, technologies and opportunities in addition to developing a variety of scientific and technical skillsets. Students in the program will work closely in teams with industry advisors and sponsors to develop innovative, relevant solutions to to current real-world problems. This approach combines academic learning and close industry connections to develop applied, practical experiences.
Opportunities for Software and IT in the Life Sciences
John Shon, Director In-Silico Sciences, Roche
November 19th, 2010 (1:00 PM - 3:00 PM Gates 4401)
Black Swans, Blockbusters, and Biotechnology: Patterns of Innovation and Value Creation
Dr. Mark Ahn, Former Vice-President Hematology, Genentech
October 8th, 2010 (1:00 PM - 3:30 PM Gates 6001)